Abstract
Systemic lupus erythematosus (SLE) is a multiorganic autoimmune disease that affects skin, osteoarticular and kidney frequently. Rituximab showed efficacy in treatment of osteoarticular and haematological SLE, but its use has been generalised for renal disease. In our case, we showed efficacy of rituximab in SLE articular disease, showing an ultrasonographic improvement.
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Murine-Derived
-
Female
-
Humans
-
Immunologic Factors / therapeutic use*
-
Lupus Erythematosus, Systemic / diagnostic imaging
-
Lupus Erythematosus, Systemic / drug therapy*
-
Lupus Erythematosus, Systemic / pathology
-
Lupus Erythematosus, Systemic / physiopathology
-
Middle Aged
-
Remission Induction
-
Rituximab
-
Ultrasonography
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Immunologic Factors
-
Rituximab